| SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19 D Nader, N Fletcher, GF Curley, SW Kerrigan PloS one 16 (6), e0253347, 2021 | 53 | 2021 |
| A new perspective in sepsis treatment: could RGD-dependent integrins be novel targets? D Nader, GF Curley, SW Kerrigan Drug Discovery Today 25 (12), 2317-2325, 2020 | 16 | 2020 |
| Molecular cross-talk between integrins and cadherins leads to a loss of vascular barrier integrity during SARS-CoV-2 infection D Nader, SW Kerrigan Viruses 14 (5), 891, 2022 | 10 | 2022 |
| Integrins as therapeutic targets for SARS-CoV-2 TE Gressett, D Nader, JP Robles, T Buranda, SW Kerrigan, G Bix Frontiers in cellular and infection microbiology 12, 892323, 2022 | 9 | 2022 |
| Human endothelial cell-derived exosomal microRNA-99a/b drives a sustained inflammatory response during sepsis by inhibiting mTOR expression G Fitzpatrick, D Nader, R Watkin, CE McCoy, GF Curley, SW Kerrigan Frontiers in Cellular and Infection Microbiology 12, 854126, 2022 | 7 | 2022 |
| Targeting Internalized Staphylococcus aureus Using Vancomycin-Loaded Nanoparticles to Treat Recurrent Bloodstream Infections D Nader, F Yousef, N Kavanagh, BK Ryan, SW Kerrigan Antibiotics 10 (5), 581, 2021 | 5 | 2021 |
| Vascular dysregulation following SARS-CoV-2 infection involves integrin signalling through a VE-Cadherin mediated pathway D Nader, S Kerrigan bioRxiv, 2022.03. 15.484274, 2022 | 1 | 2022 |
| A dual-receptor mechanism between integrins and ACE2 widens SARS-CoV-2 tissue tropism D Nader, TE Gressett, ML Hossen, P Chapagain, SW Kerrigan, G Bix bioRxiv, 2022.01. 02.474028, 2022 | 1 | 2022 |
| Taking control: hijacking of endothelial-integrin signaling networks by pathogens D Nader Royal College of Surgeons in Ireland, 2023 | | 2023 |
| A dual-receptor mechanism between integrins and ACE2 widens SARS-CoV-2 tissue tropism (preprint) D Nader, TE Gressett, ML Hossen, PP Chapagain, SW Kerrigan, G Bix | | 2022 |
